Zaire Ebolavirus Glycoprotein-directed Antibody [EPC] - N0000194038

Pharmacologic Class Information

Pharmacologic Code N0000194038
Pharmacologic Name Zaire Ebolavirus Glycoprotein-directed Antibody
Pharmacologic Uses
  • Zaire ebolavirus glycoprotein (EBOV GP)-directed human monoclonal antibody
Pharmacologic Concept Established Pharmacologic Classes - [EPC]
Pharmacologic Concept Description An established pharmacologic class is a term or phrase that is scientifically valid and clinically meaningful according to the following definitions:
  • A scientifically valid pharmacologic class is supported by documented and submitted empiric evidence showing that the drug's pharmacologic class is known, not theoretical, and relevant and specific to the indication.
  • A clinically meaningful pharmacologic class term or phrase enhances the ability of professionals to understand physiologic effects related to the indication or to anticipate undesirable effects that may be associated with the drug or pharmacologic class.

NDC Products with Zaire Ebolavirus Glycoprotein-directed Antibody

The table contains 1 products whose active ingredient are classified under the same pharmacologic class Zaire Ebolavirus Glycoprotein-directed Antibody [EPC].

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
71655-578Ebanga Non-Proprietary Name: AnsuvimabInjection, Powder, Lyophilized, For SolutionIntravenousEmergent Manufacturing Operations Baltimore, LlcACTIVE